Companies Dominating the Alcohol Use Disorder Treatment Market
- Alkermes
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Teva Pharmaceutical Industries Ltd.
- BioCorRx, Inc.
- Adial Pharmaceuticals
- Kinnov Therapeutics
- ADDEX THERAPEUTICS
- Indivior PLC
- Ethypharm
- Omeros Corporation
- Montisera Ltd./ FINNISH BIOINDUSTRIES FIB
Browse Key Market Insights with Data Illustration:
In the News
- June 2021- Alkermes plc announced that at the 2021 Research Society on Alcoholism (RSA) Scientific Meeting/International Society for Biomedical Research on Alcoholism (ISBRA) Conference, which was virtually held June 19–23, 2021, new health economics and outcomes research about healthcare resource use (HRU) among veterans with alcohol dependence was presented.
- August 2024- BioCorRx Inc. declared that it has submitted an extended access program application for BICX104 (implantable naltrexone pellet) to the US Food and Drug Administration (FDA) for the treatment of patients with opioid use disorder (OUD) who satisfy program eligibility requirements.